CClinicalTrials.gg
WithdrawnNCT02204696Updated Dec 2, 2015

Tonsillectomy in Adults With Tonsillar Hypertrophy and Obstructive Sleep Apnea

An observational study in Obstructive Sleep Apnea, sponsored by University of Southern California. Withdrawn at 1 site in United States. Open to participants aged 17 Years and older. Per ClinicalTrials.gov, last updated 2015-12-02.

Sponsored by University of Southern California · Observational

Why this study was withdrawn
No participants enrolled
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
17 Years and older
Sex
All
01

Study summary

The purpose of the study is to determine if tonsillectomy eliminates symptoms of obstructive sleep apnea in patients with obstructive sleep apnea and marked tonsillar hypertrophy with normal soft palate and uvula length.

Read the detailed description

Purpose: To determine if tonsillectomy eliminates symptoms of obstructive sleep apnea in patients with obstructive sleep apnea and marked tonsillar hypertrophy with normal soft palate and uvula length.

Specific Aims: 1. To determine if tonsillectomy eliminates obstructive sleep apnea as determined by polysomnography. 2. To determine if tonsillectomy eliminates excessive daytime sleepiness and other obstructive sleep apnea symptoms.

Rationale: Current surgical procedures for obstructive sleep apnea include tonsillectomy with soft palate surgery (including uvulopalatopharyngoplasty). Tonsillectomy alone may provide sufficient benefit in adults with marked tonsillar hypertrophy and normal soft palate and uvula length, avoiding the need for additional soft palate surgery.

Intervention: Tonsillectomy will be performed as standard of care, in patients who would be undergoing said surgery regardless of study. Study intervention includes multiple home sleep studies to determine effect of tonsillectomy in impacting symptoms of sleep apnea.

Study Population: Inclusion criteria: Subjects must be at least 18 years old, have documented obstructive sleep apnea; be willing to undergo 3 home sleep studies; and have markedly hypertrophic (3+ or 4+) tonsils. Exclusion criteria: Subjects must not have any craniofacial abnormality; normal soft palate length (\<4 cm) and uvula length ((\<2 cm); must have no history of chronic obstructive pulmonary disease, untreated psychological disorder, restless leg syndrome, alcohol or drug abuse; must have a body mass index \<35; must not plan to use continuous positive airway pressure during the study period, and lack significant nasal obstruction. The subjects will serve as their own control.

Methods and Follow Up: This two-center prospective study will include evaluation of demographics, clinical symptoms, extent of tonsillar hypertrophy, sleep habits, and home sleep studies. All subjects will undergo a 4-8 week period of watchful waiting (standard minimum delay for scheduling surgery), followed by tonsillectomy alone, with values at baseline compared to a period of watchful waiting and post-tonsillectomy.

Outcomes: Primary outcome is apnea-hypopnea index (from home sleep study). Exploratory outcomes include other sleep study results and subjective assessments (sleep-related quality of life with the Functional Outcome of Sleep Questionnaire and daytime sleepiness with the Epworth Sleepiness Scale).

Statistics and Plans for Analysis: The minimum sample size is 44 subjects, with an enrollment target of 60 subjects that will accommodate a 25% dropout rate. Standard statistical tests (e.g., paired t-tests for continuous measures) will evaluate potential differences between outcome measures at baseline vs. post-watchful waiting and baseline vs. post-tonsillectomy. Similarly, standard and appropriate statistical tests (e.g, t-tests for continuous measures) will compare changes with watchful waiting vs. tonsillectomy (e.g., baseline vs. post-watchful against baseline vs. post-tonsillectomy).

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • sleep apnea
  • obstructive sleep apnea
  • sleepiness
  • quality of life
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

Browse Apnea studies →

Lead sponsor

University of Southern California is the lead sponsor of 773 studies on the registry; 135 are open to participants now.

Of its 68 completed or terminated interventional studies of FDA-regulated products, 32 (47%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with obstructive sleep apnea and tonsillar hypertrophy

Inclusion criteria

  • At least 18 years of age
  • Documented obstructive sleep apnea (with central apneas of the total number of apneas plus hypopneas)
  • Able to complete all forms in English and follow-up appointments
  • Willing to undergo 3 home sleep studies; and markedly hypertrophic (3+ or 4+) tonsils
  • Tonsil size of 3+ or 4+ corresponds to tonsils that occupy more than 50% of the space between the tonsillar fossa (side of the throat) and midline

Exclusion criteria

Exclusion Criteria:

  • No craniofacial abnormality
  • No history of COPD, untreated psychological disorder, other sleep disorder, alcohol or drug abuse
  • Body mass index \<35 kg/m2
  • Unable to tolerate other treatments for obstructive sleep apnea
  • Soft palate length > 4 cm
  • Uvula length > 2 cm
  • No significant nasal obstruction
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Tonsillectomy

    All participants will undergo baseline sleep study, a second preoperative sleep study after a period of watchful waiting, and a postoperative sleep study.

    Procedure: Tonsillectomy

Interventions

  • ProcedureTonsillectomy

    Study participants will be scheduled for tonsillectomy based on clinical indications, with the need for surgery determined prior to study enrollment and not based on study enrollment.

06

What researchers measure

Primary outcomes

  1. apnea-hypopnea index

    This will be determined by home sleep study.

    Time frame: 8 weeks

Secondary outcomes

  1. Epworth Sleepiness Scale score

    This measure of daytime sleepiness will be assessed by questionnaire.

    Time frame: 8 weeks

  2. Functional Outcomes of Sleep Questionnaire score

    This measure of sleep-related quality of life will be assessed by questionnaire.

    Time frame: 8 weeks

Other outcomes

  1. Insomnia Severity Index

    This measure of insomnia severity will be assessed by questionnaire.

    Time frame: 8 weeks

07

Study locations

1 site
  • Keck Hospital of USC
    Los Angeles, California 90033, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02204696
Lead sponsor
University of Southern California
Collaborators
Henry Ford Health System
Responsible party
Eric Kezirian (Professor, University of Southern California) — Principal investigator
First posted
Jul 30, 2014
Start date
Dec 2010
Primary completion
Jul 2015
Completion
Jul 2015
Last update
Dec 2, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion